Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 6, 2026, CRH plc (CRH) has a Wall Street consensus price target of $135.60, based on estimates from 20 covering analysts. With the stock currently trading at $112.50, this represents a potential upside of +20.5%. The company has a market capitalization of $75.17B.
Analyst price targets range from a low of $120.00 to a high of $147.00, representing a 20% spread in expectations. The median target of $139.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CRH trades at a trailing P/E of 20.4x and forward P/E of 18.9x. The forward PEG ratio of 0.61 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow -12.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $163.25, with bear and bull scenarios of $85.35 and $227.59 respectively. Model confidence stands at 53/100, reflecting moderate uncertainty in projections.
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Linde plc.
Start ComparisonQuick answers to the most common questions about buying CRH stock.
The consensus Wall Street price target for CRH is $135.6, representing 20.5% upside from the current price of $112.5. With 20 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CRH has a consensus rating of "Buy" based on 20 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $135.6 implies 20.5% upside from current levels.
With a forward P/E of 18.8569x, CRH trades at a relatively low valuation. The consensus target of $135.6 implies 20.5% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $147 for CRH, while the most conservative target is $120. The consensus of $135.6 represents the median expectation. Our quantitative valuation model projects a bull case target of $228 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CRH is well covered by analysts, with 20 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 14 have Buy ratings, 6 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CRH stock forecast based on 20 Wall Street analysts shows a consensus price target of $135.6, with estimates ranging from $120 (bear case) to $147 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $163, with bear/bull scenarios of $85/$228.
Our quantitative valuation model calculates CRH's fair value at $163 (base case), with a bear case of $85 and bull case of $228. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 53/100.
CRH trades at a forward P/E ratio of 18.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 20.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CRH, with a "Buy" consensus rating and $135.6 price target (20.5% upside). 14 of 20 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CRH analyst price targets range from $120 to $147, a 20% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $135.6 consensus represents the middle ground. Our model's $85-$228 range provides an independent fundamental perspective.